Philogen
HealthcareBiotech & Pharma
HQ: Siena, Italy
Investors: 3 (1 current, 2 exited)
Innovative Swiss-Italian biotechnology company engaged in the research, development and manufacturing of biopharmaceutical products
Investors (3)
| Fund | Status | Entry Date | Stage | Source |
|---|---|---|---|---|
| The Equity Club | Current | - | - | Website |
| Algebris | Exited | - | - | Unknown |
| Eurizon Real Asset | Exited | - | - | Unknown |
Signals (2)
ExitThe Equity Club
2026-02-12 (observed)Philogen IPO: final results of the institutional placement
Source: The Equity Club
InvestmentThe Equity Club
2026-02-12 (observed)€62M of capital increase for Philogen, led by the Mediobanca club deal along with other investors
Source: The Equity Club